Zevra Therapeutics Inc. (ZVRA) — Cash Flow Quality Index

Latest as of June 2025: -0.05x

Zevra Therapeutics Inc. (ZVRA) has a Cash Flow Quality Index of -0.05x as of June 2025. Operating cash flow of $-3.60 Million is below net income of $74.71 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Zevra Therapeutics Inc. long-term investment intensity to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.05x

Operating CF / Net Income

Operating Cash Flow

$-3.60 Million

USD

Net Income

$74.71 Million

USD

Data as of

Jun 2025

Most recent filing

Annual Cash Flow Quality Index for Zevra Therapeutics Inc. (None–None)

Year-by-year earnings quality comparison for Zevra Therapeutics Inc.. For live market cap and the full company financial profile, see ZVRA stock market capitalisation.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.